A new study from scientists at Penn State University shows that low-calorie sweeteners, when used in amounts typical for preparing foods and beverages, do not overstimulate a person’s sweet taste buds. These results provide additional evidence that low-calorie sweeteners do not lead to sweet cravings and can be a helpful …
Read More »Monthly Archives: November 2014
Sleep Apnea May Speed Kidney Decline
A new study found that diabetes patients who had sleep apnea lost kidney function more rapidly than those who did not have the sleep disorder. Researchers found that 61 percent of the patients had a high-risk score for obstructive sleep apnea and a much greater loss of kidney function. Sleep …
Read More »Chemical In Coffee May Prevent Obesity
Researchers have discovered that a chemical compound commonly found in coffee may help prevent some of the damaging effects of obesity. Scientists found that chlorogenic acid, or CGA, significantly reduced insulin resistance and accumulation of fat in the livers of mice who were fed a high-fat diet. The researchers believe …
Read More »A Hard Pill to Swallow?
A Hard Pill to Swallow? How to Make It a Little Easier to Take It’s a common complaint: previous research has indicated that more than half of all people experience swallowing difficulties when taking tablets or capsules. Now, a research brief offers some techniques to make hard-to-swallow pills go down a …
Read More »The Zio Event Card
The Zio Event Card The ZIO® Event Card is a prescription-only, single-use, disposable, looping ECG monitor that can be worn for up to 30 days. With the profile of three stacked credit cards and weighing less than 2 ounces, the ZIO Event Card is intended to be comfortable to wear …
Read More »Letter from the Editor, #756
When the first gastric bypass was done, the incision was about 6-9 inches long. Then came lap band surgery for weight loss. We have gone from 4 incisions to one small incision over the past five years. We are always looking for less-invasive ways to help our patients lose weight …
Read More »Editor’s Note, DCMS #215
A little over five years ago, a small company came to market with a low-dose rapid-acting dopamine receptor agonist with a claim that it could reset metabolism endpoints in the neuroendocrine system. Soon as prescribers heard the word “dopamine,” red flags went up and prescribing has gone nowhere. This week …
Read More »Aaron Vinik, MD, Q2: Why BG Levels May Be Less Important than Dopamine in CVD
Dr. Aaron Vinik continues his discussion of why the “glucophiles” and those promoting lower lipids may be missing a larger picture which involves dopamine levels in the brain. In this in-depth analysis, he talks about what we may have been missing all along and some of the past research studies …
Read More »Aaron Vinik, MD, PhD, FCP, MACP: How Does Glycemic Control Relate to CV Diseases?
In answering a question on the status of cycloset as a glucose lowering drug, Dr. Aaron Vinik delves into the deeper question of how glycemic control relates to effective cardiovascular therapy. He talks about the ACCORD trial and what we learned from that, and his answers may surprise you….
Read More »Diabetes Mellitus 101 for Cardiologists, Part 6
In this week’s Homerun Slides, Dr. Stanley Schwartz talks about the Annual Cycle of Metabolism that has helped keep humans alive for tens of thousands of year but is now working to our disadvantage instead resulting in Modern Insulin Resistant Man…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.